Cargando…

The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia

BACKGROUND: A previous study reported that the myosin regulatory light chain interacting protein (MYLIP) might serve as a novel therapeutic class for treating dyslipidemia. It contributes to variations in the levels of circulating low-density lipoprotein cholesterol (LDL-C), promoting the degradatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Paulo C.J.L., Morgan, Aline C., Jannes, Cinthia E., Krieger, José E., Santos, Raul D., Pereira, Alexandre C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206345/ https://www.ncbi.nlm.nih.gov/pubmed/25171759 http://dx.doi.org/10.1097/FPC.0000000000000089

Ejemplares similares

MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population
por: Santos, Paulo C J L, et al.
Publicado: (2012)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography
por: Santos, Paulo CJL, et al.
Publicado: (2014)

Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia
por: Silva, Pãmela Rodrigues de Souza, et al.
Publicado: (2018)

CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
por: Santos, Paulo CJL, et al.
Publicado: (2011)

Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D
por: van Spaendonck-Zwarts, K. Y., et al.
Publicado: (2012)

SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group
por: Santos, Paulo CJL, et al.
Publicado: (2011)

LDLR gene’s promoter region hypermethylation in patients with familial hypercholesterolemia
por: Zorzo, R. A., et al.
Publicado: (2023)

CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells
por: Ito, Saya, et al.
Publicado: (2018)

APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population
por: Alvim, Rafael O, et al.
Publicado: (2010)

Mouse Spinal Cord Vascular Transcriptome Analysis Identifies CD9 and MYLIP as Injury-Induced Players
por: Martins, Isaura, et al.
Publicado: (2023)

Association of MYLIP rs3757354 SNP and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations
por: Yan, Ting-Ting, et al.
Publicado: (2012)

Association between UCP2 A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial disease
por: Gioli-Pereira, Luciana, et al.
Publicado: (2013)

Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system
por: Bahia, Luciana R., et al.
Publicado: (2018)

The expression of myosin-regulated light chain interacting protein (MYLIP) in lung cancer and its inhibitory effects on lung carcinomas
por: Wang, Wenhui, et al.
Publicado: (2021)

SUN-561 Genetic Variants Related to Familial Hypercholesterolemia in Clusters from Minas Gerais - a Southeast State of Brazil
por: de Paiva Silvino, Júnea Paolucci, et al.
Publicado: (2020)

New Trends and Therapies for Familial Hypercholesterolemia
por: Alnouri, Fahad, et al.
Publicado: (2022)

miR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion molecules
por: Zhao, Luqing, et al.
Publicado: (2017)

Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia
por: Hindi, Nagham N., et al.
Publicado: (2021)

Past, Present, and Future of Familial Hypercholesterolemia Management
por: Rocha, Viviane Z., et al.
Publicado: (2021)

Clinical, Anthropometric and Biochemical Characteristics of Patients with or without Genetically Confirmed Familial Hypercholesterolemia
por: Lorenzo, Andrea De, et al.
Publicado: (2018)

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
por: Tavares, Letícia C., et al.
Publicado: (2018)

NCLEX-PN®
por: Gardner, Wilda
Publicado: (2017)

The new impact factor of International Brazilian Journal of Urology is 1.342. Where can we get?
por: Favorito, Luciano A.
Publicado: (2020)

Health Tract No. 342: Lunacy
Publicado: (1868)

Bismuth Amides Mediate Facile and Highly Selective Pn–Pn Radical‐Coupling Reactions (Pn=N, P, As)
por: Oberdorf, Kai, et al.
Publicado: (2021)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia
por: Ito, Matthew K., et al.
Publicado: (2016)

Healthy Lifestyles and Cardiovascular Disease in Familial Hypercholesterolemia: Can We Change the Impact of Genes?
por: Santos, Raul D.
Publicado: (2023)

El test PN
por: Corman, Louis, 1901-
Publicado: (1985)

Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
por: Vuorio, Alpo, et al.
Publicado: (2021)

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
por: Yamashita, Shizuya, et al.
Publicado: (2022)

Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia
por: Pereira, Carolina, et al.
Publicado: (2014)

Long non-coding RNA TUSC8 inhibits breast cancer growth and metastasis via miR-190b-5p/MYLIP axis
por: Zhao, Luqing, et al.
Publicado: (2020)

Advancing Prediction of Pathogenicity of Familial Hypercholesterolemia LDL Receptor Commonest Variants With Machine Learning Models
por: Santos, Raul D.
Publicado: (2021)

Sailing the Uncharted Waters of Familial Hypercholesterolemia LDL Receptor Genetic-Related Variants: Land in Sight?
por: Santos, Raul D.
Publicado: (2023)

Interethnic diversity of NAT2 polymorphisms in Brazilian admixed populations
por: Talbot, Jhimmy, et al.
Publicado: (2010)

TNF-alpha-induced microglia activation requires miR-342: impact on NF-kB signaling and neurotoxicity
por: Brás, João Paulo, et al.
Publicado: (2020)

BDKRB2 +9/−9 Polymorphism Is Associated with Higher Risk for Diabetes Mellitus in the Brazilian General Population
por: Alvim, Rafael de Oliveira, et al.
Publicado: (2012)

PnAn13, an antinociceptive synthetic peptide inspired in the Phoneutria nigriventer toxin PnTx4(6–1) (δ-Ctenitoxin-Pn1a)
por: Emerich, Bruna Luiza, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sp7cjvk5888mgdr8tmogbqc7bd